Organigram Global (OGI) Gains from Equity Investments (2018 - 2026)

Organigram Global (OGI) has reported Gains from Equity Investments for 7 consecutive years, with $28.1 million the latest figure, recorded in Q1 2026.

• Quarterly Gains from Equity Investments rose 103.65% year-over-year to $28.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91.1 million (up 559.02% YoY) and the FY2025 annual result came in at $67.2 million, changed N/A from the prior year.
• Gains from Equity Investments fell to $28.1 million in Q1 2026 per OGI's latest filing, from $39.2 million in the prior quarter.
• Over the last five years, Gains from Equity Investments for OGI reached as high as $39.2 million in Q4 2025 and fell as low as $10.1 million in Q4 2024.
• A 3-year average of $22.8 million and a median of $20.9 million in 2025 frame the typical range for Gains from Equity Investments.
• Annual changes were most pronounced in 2025 — Gains from Equity Investments surged 287.49% — and 2026, when it soared 103.65%.
• Year by year, Gains from Equity Investments stood at $10.1 million in 2024, then jumped by 287.49% to $39.2 million in 2025, then declined by 28.27% to $28.1 million in 2026.
• According to Business Quant data, Gains from Equity Investments over the past three periods registered $28.1 million, $39.2 million, and $13.8 million for Q1 2026, Q4 2025, and Q1 2025 respectively.